| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 12/01/2022 | AbCellera Biologics Inc. | ABCL | Grant | Share Option (right to buy) | 47.2k | $13.18 | $622.5k | | 12/01/2022 |
| 09/15/2022 | Roivant Sciences Ltd. | ROIV | Grant | Stock Option (Right to Buy) | 71.8k | $3.50 | $251.5k | | 09/15/2022 |
| 09/15/2022 | Roivant Sciences Ltd. | ROIV | Grant | Common Shares | 52.1k | $0.00 | $0 | | 09/15/2022 |
| 06/22/2022 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (right to buy) | 104.9k | $8.45 | $886.6k | | 06/22/2022 |
| 12/30/2021 | BridgeBio Pharma, Inc. | BBIO | Purchase | Common Stock | 1.5k | $14.30 | $21.4k | | 12/29/2021 |
| 12/29/2021 | BridgeBio Pharma, Inc. | BBIO | Purchase | Common Stock | 6k | $12.90 | $77.4k | | 12/29/2021 |
| 12/03/2021 | AbCellera Biologics Inc. | ABCL | Purchase | Share Option (right to buy) | 86.9k | $14.02 | $1.2M | | 12/03/2021 |
| 12/03/2021 | AbCellera Biologics Inc. | ABCL | Grant | Share Option (right to buy) | 91.3k | $14.02 | $1.3M | | 12/03/2021 |
| 06/17/2021 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (right to buy) | 38.9k | $62.63 | $2.4M | | 06/17/2021 |
| 06/23/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 101.2k | $32.62 | $3.3M | | 06/23/2020 |
| 06/19/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 5k | $8.17 | $40.5k | See footnotes | 06/17/2019 |
| 06/18/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 6.7k | $8.21 | $55.1k | See footnotes | 06/17/2019 |
| 06/17/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 6.5k | $8.53 | $55.8k | See footnotes | 06/17/2019 |
| 06/14/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.1k | $7.91 | $56.5k | See footnotes | 06/12/2019 |
| 06/13/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.4k | $7.95 | $58.5k | See footnotes | 06/12/2019 |
| 06/12/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.5k | $8.30 | $62.2k | See footnotes | 06/12/2019 |
| 06/11/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.2k | $8.58 | $61.7k | See footnotes | 06/07/2019 |
| 06/10/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.5k | $8.35 | $62.6k | See footnotes | 06/07/2019 |
| 06/07/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 6.6k | $7.97 | $53k | See footnotes | 06/07/2019 |
| 06/06/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.1k | $8.00 | $56.6k | See footnotes | 06/04/2019 |
| 06/05/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 6.5k | $8.02 | $52.4k | See footnotes | 06/04/2019 |
| 06/04/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, $0.000017727 par value per share | 2.4M | $8.25 | $20M | See footnotes | 06/04/2019 |
| 06/04/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.5k | $7.59 | $56.9k | See footnotes | 06/04/2019 |
| 06/03/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 5.4k | $7.71 | $41.8k | See footnotes | 05/30/2019 |
| 05/31/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 5.1k | $7.70 | $39k | See footnotes | 05/30/2019 |
| 05/30/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 300 | $8.91 | $2.7k | See footnotes | 05/30/2019 |
| 05/30/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7k | $7.97 | $55.4k | See footnotes | 05/30/2019 |
| 05/29/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 6.9k | $7.55 | $52k | See footnotes | 05/24/2019 |
| 05/28/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 3.8k | $7.68 | $29.2k | See footnotes | 05/24/2019 |
| 05/24/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 3.8k | $7.70 | $29.2k | See footnotes | 05/24/2019 |
| 05/23/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 4.8k | $7.76 | $37.3k | See Footnote | 05/21/2019 |
| 05/22/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 5k | $8.06 | $40.6k | See Footnote | 05/21/2019 |
| 05/21/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 10k | $8.52 | $85.1k | See Footnote | 05/21/2019 |
| 05/20/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 8.3k | $7.98 | $66.1k | See Footnote | 05/16/2019 |
| 05/20/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 1.7k | $8.39 | $14.4k | See Footnote | 05/16/2019 |
|